Albemarle (NYSE:ALB) Sets New 52-Week Low - Should You Sell?

Albemarle Co. (NYSE:ALB - Get Free Report) shares hit a new 52-week low during trading on Monday . The stock traded as low as $71.96 and last traded at $71.73, with a volume of 2848446 shares traded. The stock had previously closed at $77.03.

Wall Street Analysts Forecast Growth

ALB has been the topic of a number of research analyst reports. Morgan Stanley decreased their price objective on shares of Albemarle from $73.00 to $68.00 and set an "underweight" rating on the stock in a report on Tuesday, February 18th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Albemarle from $109.00 to $105.00 in a report on Wednesday, February 12th. Evercore ISI downgraded shares of Albemarle from an "outperform" rating to an "inline" rating in a report on Wednesday, February 5th. KeyCorp reduced their price objective on Albemarle from $127.00 to $122.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. Finally, UBS Group cut their price target on shares of Albemarle from $99.00 to $86.00 and set a "neutral" rating on the stock in a research report on Thursday, February 13th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $109.68.

Albemarle Stock Performance

The firm has a market cap of $8.22 billion, a price-to-earnings ratio of -6.24 and a beta of 1.59. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39. The stock has a 50 day moving average of $85.10 and a 200 day moving average of $92.19.

Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. As a group, analysts anticipate that Albemarle Co. will post -0.04 EPS for the current fiscal year.

Albemarle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, March 14th will be given a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date is Friday, March 14th. Albemarle's dividend payout ratio is -14.46%.

Insider Transactions at Albemarle

In related news, CEO J Kent Masters sold 2,525 shares of the stock in a transaction on Thursday, December 5th. The stock was sold at an average price of $101.12, for a total value of $255,328.00. Following the completion of the sale, the chief executive officer now directly owns 73,747 shares in the company, valued at $7,457,296.64. This represents a 3.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.38% of the company's stock.

Institutional Investors Weigh In On Albemarle

A number of institutional investors have recently made changes to their positions in ALB. Quarry LP boosted its holdings in Albemarle by 1,400.0% in the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 252 shares during the last quarter. Assetmark Inc. boosted its stake in shares of Albemarle by 340.6% in the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock valued at $26,000 after purchasing an additional 235 shares during the last quarter. Trust Co. of Vermont increased its position in shares of Albemarle by 606.5% during the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company's stock worth $28,000 after buying an additional 279 shares during the period. First Community Trust NA lifted its stake in Albemarle by 55.0% in the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company's stock valued at $34,000 after buying an additional 142 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in Albemarle during the fourth quarter worth $34,000. Institutional investors own 92.87% of the company's stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.